NDC 50072-200

TPOXX

Tecovirimat Monohydrate

TPOXX is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Siga Technologies, Inc.. The primary component is Tecovirimat Monohydrate.

Product ID50072-200_638105d6-2895-4ab5-b1ef-3b5d95c196fa
NDC50072-200
Product TypeHuman Prescription Drug
Proprietary NameTPOXX
Generic NameTecovirimat Monohydrate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2018-08-31
Marketing CategoryNDA / NDA
Application NumberNDA208627
Labeler NameSIGA Technologies, Inc.
Substance NameTECOVIRIMAT MONOHYDRATE
Active Ingredient Strength200 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50072-200-42

42 CAPSULE in 1 BOTTLE (50072-200-42)
Marketing Start Date2018-08-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50072-200-42 [50072020042]

TPOXX CAPSULE
Marketing CategoryNDA
Application NumberNDA208627
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31

Drug Details

Active Ingredients

IngredientStrength
TECOVIRIMAT MONOHYDRATE200 mg/1

OpenFDA Data

SPL SET ID:fce826ab-4d6a-4139-a2ee-a304a913a253
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2055115
  • 2055109
  • UPC Code
  • 0350072200427
  • NDC Crossover Matching brand name "TPOXX" or generic name "Tecovirimat Monohydrate"

    NDCBrand NameGeneric Name
    50072-010TPOXXtecovirimat monohydrate
    50072-200TPOXXtecovirimat monohydrate

    Trademark Results [TPOXX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TPOXX
    TPOXX
    86409863 5046109 Live/Registered
    SIGA Technologies, Inc.
    2014-09-30

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.